AAAAAA

   
Results: 1-9 |
Results: 9

Authors: MACIAS WL BERGSTROM RF CERIMELE BJ KASSAHUN K TATUM DE CALLAGHAN JT
Citation: Wl. Macias et al., LACK OF EFFECT OF OLANZAPINE ON THE PHARMACOKINETICS OF A SINGLE AMINOPHYLLINE DOSE IN HEALTHY-MEN, Pharmacotherapy, 18(6), 1998, pp. 1237-1248

Authors: LUCAS RA GILFILLAN DJ BERGSTROM RF
Citation: Ra. Lucas et al., A PHARMACOKINETIC INTERACTION BETWEEN CARBAMAZEPINE AND OLANZAPINE - OBSERVATIONS ON POSSIBLE MECHANISM, European Journal of Clinical Pharmacology, 54(8), 1998, pp. 639-643

Authors: BLUMENFIELD M LEVY NB SPINOWITZ B CHARYTAN C BEASLEY CM DUBEY AK SOLOMON RJ TODD R GOODMAN A BERGSTROM RF
Citation: M. Blumenfield et al., FLUOXETINE IN DEPRESSED-PATIENTS ON DIALYSIS, International journal of psychiatry in medicine, 27(1), 1997, pp. 71-80

Authors: BERGSTROM RF GOLDBERG MJ CERIMELE BJ HATCHER BL
Citation: Rf. Bergstrom et al., ASSESSMENT OF THE POTENTIAL FOR A PHARMACOKINETIC INTERACTION BETWEENFLUOXETINE AND TERFENADINE, Clinical pharmacology and therapeutics, 62(6), 1997, pp. 643-651

Authors: KURTZ DL BERGSTROM RF GOLDBERG MJ CERIMELE BJ
Citation: Dl. Kurtz et al., THE EFFECT OF SERTRALINE ON THE PHARMACOKINETICS OF DESIPRAMINE AND IMIPRAMINE, Clinical pharmacology and therapeutics, 62(2), 1997, pp. 145-156

Authors: GOLDBERG MJ BERGSTROM RF CERIMELE BJ THOMASSON HR HATCHER BL SIMCOX EA
Citation: Mj. Goldberg et al., FLUOXETINE EFFECTS ON PINDOLOL PHARMACOKINETICS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 51-51

Authors: MAYA JF CALLAGHAN JT BERGSTROM RF CERIMELE BJ KASSAHUN K NYHART EH BRATER DC
Citation: Jf. Maya et al., OLANZAPINE AND WARFARIN DRUG-INTERACTION, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 67-67

Authors: LEVY NB BLUMENFIELD M BEASLEY CM DUBEY AK SOLOMON RJ TODD R GOODMAN A BERGSTROM RF
Citation: Nb. Levy et al., FLUOXETINE IS SAFE AND EFFICACIOUS IN DEPRESSED HEMODIALYSIS-PATIENTS, Psychosomatics, 37(2), 1996, pp. 211-211

Authors: BERGSTROM RF BEASLEY CM LEVY NB BLUMENFIELD M LEMBERGER L
Citation: Rf. Bergstrom et al., THE EFFECTS OF RENAL AND HEPATIC-DISEASE ON THE PHARMACOKINETICS, RENAL TOLERANCE, AND RISK-BENEFIT PROFILE OF FLUOXETINE, International clinical psychopharmacology, 8(4), 1993, pp. 261-266
Risultati: 1-9 |